diltiazem has been researched along with quinapril in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cachofeiro, V; Casal, MC; Lahera, V; Maeso, R; Navarro-Cid, J; Perez-Vizcaino, F; Ruilope, LM; Tamargo, J | 1 |
| Cachofeiro, V; Lahera, V; Maeso, R; Muñoz-García, R; Navarro-Cid, J; Rodrigo, E; Ruilope, LM | 1 |
| Araújo, D; Cabezas-Cerrato, J; Garcia-Estevez, DA; Iglesias, M | 1 |
| Cachofeiro, V; Lahera, V; Maeso, R; Navarro-Cid, J; Rodrigo, E; Ruilope, LM | 1 |
| Blanco, S; Casas, I; López, D; Penin, R; Romero, R | 1 |
| Bauer, C; George, I; Godes, M; Hocher, B; Neumayer, HH; Olivier, J; Thöne-Reineke, C; Zart, R | 1 |
| Blanco, S; Bonet, J; Casas, I; López, D; Romero, R | 1 |
1 review(s) available for diltiazem and quinapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for diltiazem and quinapril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of antihypertensive drugs on blood pressure and metabolic alterations in the fructose-induced hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diltiazem; Fructose; Glucose Tolerance Test; Hypertension; Insulin Resistance; Isoquinolines; Kidney Function Tests; Lipids; Male; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Triglycerides | 1996 |
Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diltiazem; Diuresis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoquinolines; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Quinapril; Random Allocation; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Tetrahydroisoquinolines | 1996 |
Insulin sensitivity, glucose effectiveness, and beta-cell function in obese males with essential hypertension: investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril).
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diltiazem; Glucose Tolerance Test; Humans; Hypertension; Insulin Resistance; Islets of Langerhans; Isoquinolines; Male; Middle Aged; Obesity; Quinapril; Tetrahydroisoquinolines | 1997 |
Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Diltiazem; Disease Models, Animal; Endothelium, Vascular; Hypertension; Isoquinolines; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation; Vasodilator Agents | 1999 |
Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Disease Models, Animal; Drug Therapy, Combination; Linear Models; Male; Obesity; Podocytes; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines | 2002 |
Effects of angiotensin-converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two-kidney/one-clip) renovascular hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Blood Pressure; Calcium Channel Blockers; Diltiazem; Hypertension, Renovascular; Hypertrophy, Left Ventricular; In Situ Nick-End Labeling; Isoquinolines; Male; Myocardium; Organ Size; Quinapril; Rats; Rats, Inbred WKY; Tetrahydroisoquinolines; Ventricular Remodeling | 2003 |
ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; DNA, Complementary; Immunoenzyme Techniques; Male; Membrane Proteins; Microfilament Proteins; Obesity; Proteins; Quinapril; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrahydroisoquinolines | 2005 |